I can't see that this is the reason for the savage share drop from mid May. This is a one-off settlement for A$33.3M(after insurance) but the loss in market capitalisation since May has been close to A$250M. In my opinion, the loss in market value of the company remains unexplained.
They have reasserted their guidance, now with 100% certainty, as another poster has said, I believe that this management is clearing the remaining legacy issues with an expectation of a clean result for FY2025.
Cashflow for the business will be interesting, A$146.8M in December, less $33.3M for this and possibly $10-20M for generics legacy issues after selling this business to Dr Reddy, offset by whatever positive cash they have generated from ongoing businesses, I am guessing there's still around A$100M left to start FY 2025, where positive cashflows are expected for the full year and no legacy issues (that I am aware of).
Turning this company around was never going to be easy or quick. All eyes will be on the FY2024 result in August with particular interest in WH for the last 3 months.
MYX Price at posting:
$4.42 Sentiment: Buy Disclosure: Held
